Skip to main content
Top
Published in: Journal of Neurology 1/2010

01-01-2010 | Original Communication

Non-motor symptoms in atypical and secondary parkinsonism: the PRIAMO study

Authors: Carlo Colosimo, Letterio Morgante, Angelo Antonini, Paolo Barone, Tania P. Avarello, Edo Bottacchi, Antonino Cannas, Maria Gabriella Ceravolo, Roberto Ceravolo, Giulio Cicarelli, Rosa M. Gaglio, Luisa Giglia, Francesco Iemolo, Michela Manfredi, Giuseppe Meco, Alessandra Nicoletti, Massimo Pederzoli, Alfredo Petrone, Antonio Pisani, Francesco E. Pontieri, Rocco Quatrale, Silvia Ramat, Rossana Scala, Giampiero Volpe, Salvatore Zappulla, Anna Rita Bentivoglio, Fabrizio Stocchi, Giorgio Trianni, Paolo Del Dotto, Lucia Simoni, Roberto Marconi, and PRIAMO STUDY GROUP

Published in: Journal of Neurology | Issue 1/2010

Login to get access

Abstract

The PRIAMO study is a cross-sectional longitudinal observational study aimed at describing epidemiology and evolution of non-motor symptoms (NMS) in patients with different forms of parkinsonism recruited in 55 Italian centres and evaluated over 24 months. In this paper, we are reporting prevalence and clinical characteristics of NMS in patients with atypical and secondary parkinsonism. Out of 1307 consecutive patients with a diagnosis of parkinsonism, 83 patients had vascular parkinsonism (VP), 34 had multiple system atrophy (MSA), 30 had progressive supranuclear palsy (PSP), 14 had dementia with Lewy bodies (DLB) and 11 had corticobasal degeneration (CBD). MSA and DLB had the highest number of NMS domains and symptoms, respectively. Gastrointestinal symptoms, pain, urinary problems and postural instability due to orthostatic hypotension were most frequent in MSA. Sleep disturbances were also common with a prevalence of approximately 70% in all diagnostic groups but CBD (36%). Psychiatric symptoms and attention and memory impairment were frequently observed in all diagnoses but were most prevalent among DLB patients, whereas the prevalence of skin and respiratory disorders was rather low in all forms, ranging between 10 and 30%. Atypical parkinsonism patients also reported a low QoL, with no significant differences among the different forms, whereas PD and VP patients had a better QoL.
Appendix
Available only for authorised users
Literature
1.
go back to reference Antonini A, Colosimo C, Marconi R, Morgante L, Barone P (2008) The PRIAMO Study: background, methods and recruitment. Neurol Sci 2:61–65CrossRef Antonini A, Colosimo C, Marconi R, Morgante L, Barone P (2008) The PRIAMO Study: background, methods and recruitment. Neurol Sci 2:61–65CrossRef
2.
go back to reference Appollonio I, Leone M, Isella V et al (2005) The Frontal Assessment Battery (FAB): normative values in an Italian population sample. Neurol Sci 26:108–116CrossRefPubMed Appollonio I, Leone M, Isella V et al (2005) The Frontal Assessment Battery (FAB): normative values in an Italian population sample. Neurol Sci 26:108–116CrossRefPubMed
3.
go back to reference Bensimon G, Ludolph A, Agid Y, Vidailhet M, Payan C, Leigh PN (2009) NNIPPS Study Group Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study. Brain 132:156–171CrossRefPubMed Bensimon G, Ludolph A, Agid Y, Vidailhet M, Payan C, Leigh PN (2009) NNIPPS Study Group Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study. Brain 132:156–171CrossRefPubMed
4.
go back to reference Chaudhuri KR, Healy DG, Schapira A (2006) Non-motor symptoms of Parkinson’s disease: diagnosis and management. Lancet Neurol 5:235–245CrossRefPubMed Chaudhuri KR, Healy DG, Schapira A (2006) Non-motor symptoms of Parkinson’s disease: diagnosis and management. Lancet Neurol 5:235–245CrossRefPubMed
5.
go back to reference Colosimo C, Geser F, Benarroch EE, Wenning GK (2007) Multiple system atrophy. In: Gilman S (ed) Neurobiology of disease. Academic Press, CA, pp 200–202 Colosimo C, Geser F, Benarroch EE, Wenning GK (2007) Multiple system atrophy. In: Gilman S (ed) Neurobiology of disease. Academic Press, CA, pp 200–202
6.
go back to reference Colosimo C, Tiple D, Berardelli A (2008) Clinical differential diagnosis of parkinsonism. Future Neurol 3:287–298CrossRef Colosimo C, Tiple D, Berardelli A (2008) Clinical differential diagnosis of parkinsonism. Future Neurol 3:287–298CrossRef
7.
go back to reference Dubois B, Slachevsky A, Litvan I et al (2000) The FAB: a Frontal Assessment Battery at bedside. Neurology 55:1621–1626PubMed Dubois B, Slachevsky A, Litvan I et al (2000) The FAB: a Frontal Assessment Battery at bedside. Neurology 55:1621–1626PubMed
8.
go back to reference Fahn S, Elton R, Members of the UPDRS Development Committee (1987) The Unified Parkinson’s Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M, eds. Recent developments in Parkinson’s disease, vol 2. Macmillan Health Care Information, Florham Park, pp 153–63, 293–304 Fahn S, Elton R, Members of the UPDRS Development Committee (1987) The Unified Parkinson’s Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M, eds. Recent developments in Parkinson’s disease, vol 2. Macmillan Health Care Information, Florham Park, pp 153–63, 293–304
9.
go back to reference Folstein MF, Folstein SE, McHugh PR (1975) “Mini-Mental State”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198CrossRefPubMed Folstein MF, Folstein SE, McHugh PR (1975) “Mini-Mental State”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198CrossRefPubMed
10.
go back to reference Ford B, Louise P, Greene P et al (1996) Oral and genital pain syndromes in Parkinson’s disease. Mov Disord 11:421–426CrossRefPubMed Ford B, Louise P, Greene P et al (1996) Oral and genital pain syndromes in Parkinson’s disease. Mov Disord 11:421–426CrossRefPubMed
11.
go back to reference Gelb DJ, Oliver E, Gilman S (1999) Diagnostic criteria for Parkinson disease. Arch Neurol 56:33–39CrossRefPubMed Gelb DJ, Oliver E, Gilman S (1999) Diagnostic criteria for Parkinson disease. Arch Neurol 56:33–39CrossRefPubMed
12.
go back to reference Gilman S, Low PA, Quinn N et al (1999) Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 163:94–98CrossRefPubMed Gilman S, Low PA, Quinn N et al (1999) Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 163:94–98CrossRefPubMed
13.
go back to reference Gilman S, Wenning GK, Low PA et al (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71:670–676CrossRefPubMed Gilman S, Wenning GK, Low PA et al (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71:670–676CrossRefPubMed
14.
15.
go back to reference Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427–442PubMed Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427–442PubMed
16.
go back to reference Litvan I (2005) Atypical Parkinsonian disorders—clinical and research aspects. Humana Press, Totowa Litvan I (2005) Atypical Parkinsonian disorders—clinical and research aspects. Humana Press, Totowa
17.
18.
go back to reference Litvan I, Agid Y, Calne D et al (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 47:1–9PubMed Litvan I, Agid Y, Calne D et al (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 47:1–9PubMed
19.
go back to reference Litvan I, Bhatia KP, Burn DJ et al (2003) Movement Disorders Society Scientific Issues Committee report: SIC task force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord 18:467–486CrossRefPubMed Litvan I, Bhatia KP, Burn DJ et al (2003) Movement Disorders Society Scientific Issues Committee report: SIC task force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord 18:467–486CrossRefPubMed
20.
go back to reference Litvan I, Campbell G, Mangone CA et al (1997) Which clinical features differentiate progressive supranuclear palsy from related disorders? A clinicopathological study. Brain 12:65–74CrossRef Litvan I, Campbell G, Mangone CA et al (1997) Which clinical features differentiate progressive supranuclear palsy from related disorders? A clinicopathological study. Brain 12:65–74CrossRef
21.
go back to reference Mamikonyan E, Moberg PJ, Siderowf A, Duda JE, Have TT, Hurtig HI, Stern MB, Weintraub D (2009) Mild cognitive impairment is common in Parkinson’s disease patients with normal Mini-Mental State Examination (MMSE) scores. Parkinsonism Relat Disord 15:226–231CrossRefPubMed Mamikonyan E, Moberg PJ, Siderowf A, Duda JE, Have TT, Hurtig HI, Stern MB, Weintraub D (2009) Mild cognitive impairment is common in Parkinson’s disease patients with normal Mini-Mental State Examination (MMSE) scores. Parkinsonism Relat Disord 15:226–231CrossRefPubMed
22.
go back to reference McDowell I, Newell C (1996) Measuring health: a guide to rating scales and questionnaires. Oxford University Press, New York McDowell I, Newell C (1996) Measuring health: a guide to rating scales and questionnaires. Oxford University Press, New York
23.
go back to reference McKeith IG, Dickson DW, Lowe J et al (2005) Diagnosis and management of dementia with Lewy bodies: third report of the LBD consortium. Neurology 65:1863–1872CrossRefPubMed McKeith IG, Dickson DW, Lowe J et al (2005) Diagnosis and management of dementia with Lewy bodies: third report of the LBD consortium. Neurology 65:1863–1872CrossRefPubMed
24.
25.
go back to reference Measso GF, Cavarzeran F, Zappalà G et al (1993) The Mini-Mental State Examination: normative study of a random sample of Italian population. Dev Neuropsychol 9:77–85CrossRef Measso GF, Cavarzeran F, Zappalà G et al (1993) The Mini-Mental State Examination: normative study of a random sample of Italian population. Dev Neuropsychol 9:77–85CrossRef
26.
go back to reference Morgante L, Rocca WA, Di Rosa AE et al (1992) Prevalence of Parkinson’s disease and other types of parkinsonism: a door-to-door survey in three Sicilian municipalities. The Sicilian Neuro-Epidemiologic Study (SNES) Group. Neurology 42:1901–1907PubMed Morgante L, Rocca WA, Di Rosa AE et al (1992) Prevalence of Parkinson’s disease and other types of parkinsonism: a door-to-door survey in three Sicilian municipalities. The Sicilian Neuro-Epidemiologic Study (SNES) Group. Neurology 42:1901–1907PubMed
27.
go back to reference Müller J, Wenning GK, Jellinger K, McKee A, Poewe W, Litvan I (2000) Progression of Hoehn and Yahr stages in Parkinsonian disorders: a clinicopathologic study. Neurology 55:888–891PubMed Müller J, Wenning GK, Jellinger K, McKee A, Poewe W, Litvan I (2000) Progression of Hoehn and Yahr stages in Parkinsonian disorders: a clinicopathologic study. Neurology 55:888–891PubMed
28.
go back to reference Peto V, Jenkinson C, Fitzpatrick R et al (1995) The development and validation of a short measure of functioning and well being for individuals with Parkinson’s disease. Qual Life Res 4:241–248CrossRefPubMed Peto V, Jenkinson C, Fitzpatrick R et al (1995) The development and validation of a short measure of functioning and well being for individuals with Parkinson’s disease. Qual Life Res 4:241–248CrossRefPubMed
29.
go back to reference Quinn N, Koller WC, Lang AE et al (1996) Painful Parkinson’s disease. Lancet 1:1366–1369 Quinn N, Koller WC, Lang AE et al (1996) Painful Parkinson’s disease. Lancet 1:1366–1369
30.
go back to reference Riley DE, Lang AE (2000) Clinical diagnostic criteria of corticobasal degeneration. Adv Neurol 82:1233–1245 Riley DE, Lang AE (2000) Clinical diagnostic criteria of corticobasal degeneration. Adv Neurol 82:1233–1245
31.
go back to reference Stamelou M, Reuss A, Pilatus U et al (2008) Short-term effects of coenzyme Q10 in progressive supranuclear palsy: a randomized, placebo-controlled trial. Mov Disord 23:942–949CrossRefPubMed Stamelou M, Reuss A, Pilatus U et al (2008) Short-term effects of coenzyme Q10 in progressive supranuclear palsy: a randomized, placebo-controlled trial. Mov Disord 23:942–949CrossRefPubMed
32.
go back to reference Tison F, Wenning GK, Volonte MA et al (1996) Pain in multiple system atrophy. J Neurol 243:153–156CrossRefPubMed Tison F, Wenning GK, Volonte MA et al (1996) Pain in multiple system atrophy. J Neurol 243:153–156CrossRefPubMed
33.
go back to reference Tuite PJ, Krawczewski K (2007) Parkinsonism: a review-of-system approach to diagnosis. Semin Neurol 27:113–122CrossRefPubMed Tuite PJ, Krawczewski K (2007) Parkinsonism: a review-of-system approach to diagnosis. Semin Neurol 27:113–122CrossRefPubMed
34.
35.
go back to reference Williams DR, Lees AJ (2009) Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges. Lancet Neurol 8:270–279CrossRefPubMed Williams DR, Lees AJ (2009) Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges. Lancet Neurol 8:270–279CrossRefPubMed
36.
go back to reference Zijlmans JC, Daniel SE, Hughes AJ, Révész T, Lees AJ (2004) Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis. Mov Disord 19:630–640CrossRefPubMed Zijlmans JC, Daniel SE, Hughes AJ, Révész T, Lees AJ (2004) Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis. Mov Disord 19:630–640CrossRefPubMed
Metadata
Title
Non-motor symptoms in atypical and secondary parkinsonism: the PRIAMO study
Authors
Carlo Colosimo
Letterio Morgante
Angelo Antonini
Paolo Barone
Tania P. Avarello
Edo Bottacchi
Antonino Cannas
Maria Gabriella Ceravolo
Roberto Ceravolo
Giulio Cicarelli
Rosa M. Gaglio
Luisa Giglia
Francesco Iemolo
Michela Manfredi
Giuseppe Meco
Alessandra Nicoletti
Massimo Pederzoli
Alfredo Petrone
Antonio Pisani
Francesco E. Pontieri
Rocco Quatrale
Silvia Ramat
Rossana Scala
Giampiero Volpe
Salvatore Zappulla
Anna Rita Bentivoglio
Fabrizio Stocchi
Giorgio Trianni
Paolo Del Dotto
Lucia Simoni
Roberto Marconi
and PRIAMO STUDY GROUP
Publication date
01-01-2010
Publisher
D. Steinkopff-Verlag
Published in
Journal of Neurology / Issue 1/2010
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-009-5255-7

Other articles of this Issue 1/2010

Journal of Neurology 1/2010 Go to the issue